- Home
- About
- Find staff
- Larsolof Hafström
Larsolof Hafström
-
The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver
disease
Helena Taflin, Lars-Olof Hafström, Erik Holmberg, Maria Castedal, Per Lindnér
Scandinavian Journal of Gastroenterology - 2019 -
The Consequences of Negligence Claims in Arterial Surgery – An Analysis of Two Periods with an Increasing Use of Endovascular
Treatment
D. Bergqvist, Lars-Olof Hafström, P. Gustafson
European Journal of Vascular and Endovascular Surgery - 2019 -
Gallbladder cancer - no improvement in survival over time in a Swedish
population
Per Lindnér, Erik Holmberg, Lars-Olof Hafström
Acta Oncologica - 2018 -
Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities - Long-term follow-up of a randomised
trial
Roger Olofsson Bagge, Jan Mattsson, Lars-Olof Hafström
International Journal of Hyperthermia - 2014 -
Mag-tarmkanalens
cancersjukdomar
Lars-Olof Hafström, Peter Naredi, Bengt Glimelius
2013 -
Kirurgisk
onkologi.I:Kirurgi.
-
Type IV collagen as a tumour marker for colorectal liver
metastases.
H Nyström, Peter Naredi, Lars-Olof Hafström, M Sund
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 2011 -
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - a randomized trial from the South Sweden Breast Cancer
Group.
Fredrika Killander, Harald Anderson, Stefan Rydén, Torgil Möller, Lars-Olof Hafström, Per Malmström
Breast (Edinburgh, Scotland) - 2009 -
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular
cancer.
Magnus Rizell, Mats Andersson, Christian Cahlin, Lars-Olof Hafström, Michael Olausson, Per Lindnér
International journal of clinical oncology / Japan Society of Clinical Oncology - 2008 -
Isolated hepatic perfusion for liver metastases of malignant
melanoma.
Magnus Rizell, Jan Mattson, Christian Cahlin, Lars-Olof Hafström, Per Lindnér, Michael Olausson
Melanoma research - 2008 -
Extended right-sided liver resection for colorectal liver metastases--impact of percutaneous portal venous
embolisation
Per Lindnér, Christian Cahlin, Styrbjörn Friman, Lars-Olof Hafström, H. Klingenstierna, Lars Lönn, Michael Olausson, M. Rizell
European journal of surgical oncology - 2006 -
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas
cancer
Mikael Oman, S. Lundqvist, Bengt Gustavsson, Lars-Olof Hafström, Peter Naredi
Cancer Chemother Pharmacol - 2005 -
Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance
technique.
M Oman, J Tölli, Peter Naredi, Lars-Olof Hafström
Cancer chemotherapy and pharmacology - 2004 -
Blood flow in liver tumors--effects of vasoactive drugs estimated with xenon (133Xe)
clearance.
Per Lindnér, J Tölli, Peter Naredi, M Oman, Lars-Olof Hafström
Hepato-gastroenterology - 2004 -
133Xe clearance estimates the effect of vasopressin on peritoneal blood flow in
rats.
M Oman, J Tölli, P J Blind, Peter Naredi, Lars-Olof Hafström
Hepato-gastroenterology - 2004 -
A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver
metastases.
Peter Naredi, M Oman, P-J Blind, Per Lindnér, Bengt Gustavsson, Lars-Olof Hafström
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 2003 -
Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin
IV.
M Oman, P J Blind, Peter Naredi, Bengt Gustavsson, Lars-Olof Hafström
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 2001 -
P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver
resection.
Y Yang, Ann Forslund, H Remotti, Christina Lönnroth, M Andersson, Hans Brevinge, Elisabeth Svanberg, Per Lindnér, Lars-Olof Hafström, Peter Naredi, Kent Lundholm
Cancer - 2001 -
Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and
melphalan.
Per Lindnér, M Fjälling, Lars-Olof Hafström, H Kierulff-Nielsen, J Mattsson, Tore Scherstén, Magnus Rizell, Peter Naredi
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1999 -
Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish
experience.
Lars-Olof Hafström, Peter Naredi
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer - 1998 -
Treatment of primary liver
cancer.
Lars-Olof Hafström, Peter Naredi, Per Lindnér, Stig B Holmberg, Tore Scherstén
The European journal of surgery = Acta chirurgica - 1998 -
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial
administration.
Per Lindnér, D Heath, S B Howell, Peter Naredi, Lars-Olof Hafström
Cancer chemotherapy and pharmacology - 1997 -
The influence of zymosan and indomethacin on liver and kidney tumor growth. An experimental study in
rats.
M G Ohman, P Blind, Stig B Holmberg, Peter Naredi, Per Lindnér, Lars-Olof Hafström
Journal of experimental & clinical cancer research : CR - 1997 -
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal
administration.
Per Lindnér, D Heath, S Howell, Peter Naredi, Lars-Olof Hafström
Clinical cancer research : an official journal of the American Association for Cancer Research - 1996 -
Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in
rats.
Stig B Holmberg, Peter Naredi, Per Lindnér, Ingvar Karlberg, Peter Daneryd, Lilian M. Karlsson, Anders Pettersson, U Stenram, Lars-Olof Hafström
Journal of cancer research and clinical oncology - 1995 -
Influence of hepatic artery occlusion and desferrioxamine on liver-tumour
growth.
Per Lindnér, Peter Naredi, A Peterson, Lars-Olof Hafström
International journal of cancer. Journal international du cancer - 1995 -
Isolated hyperthermic liver perfusion with chemotherapy for liver
malignancy.
Lars-Olof Hafström, Stig B Holmberg, Peter Naredi, Per Lindnér, Anders Bengtsson, G Tidebrant, Tore Scherstén
Surgical oncology - 1994 -
Histamine in immunotherapy of advanced melanoma: a pilot
study.
Kristoffer Hellstrand, Peter Naredi, Per Lindnér, Kent Lundholm, Carl-Magnus Rudenstam, Svante Hermodsson, Mats Asztely, Lars-Olof Hafström
Cancer immunology, immunotherapy : CII - 1994 -
Quantitative measurements of collateral arterial blood flow in nonarterialized rat liver
grafts.
G Svensson, Peter Naredi, Lars-Olof Hafström, G Tufveson
Transplant international : official journal of the European Society for Organ Transplantation - 1994 -
Whole body energy expenditure protein breakdown and polyamine excretion during high dose treatment with interleukin-2 and
interferon-alpha.
Peter Naredi, Lars-Olof Hafström, H Zachrisson, Carl-Magnus Rudenstam, Kent Lundholm
The European journal of surgery = Acta chirurgica - 1994 -
Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the
liver.
Per Lindnér, G Carlsson, Bengt Gustavsson, Stig B Holmberg, Peter Naredi, A Peterson, Lars-Olof Hafström
Anticancer research - 1994 -
Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical
trial.
Lars-Olof Hafström, Boel Engarås, Stig B Holmberg, Bengt Gustavsson, P E Jönsson, Per Lindnér, Peter Naredi, G Tidebrant
Cancer - 1994 -
Hepatic artery occlusion and energy charge in rat liver
tumour.
Per Lindnér, Björn Biber, Bengt Gustavsson, Stig B Holmberg, Peter Naredi, Lars-Olof Hafström
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO - 1994 -
Vascular clearance by liver sinusoidal cells and hepatocytes after liver resection in
rats.
Stig B Holmberg, Peter Naredi, G Svensson, L Jacobsson, Lars-Olof Hafström
Cells of the hepatic sinusoid. eds: Kirn A, Knook DL, Wisse E - 1993 -
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and
etoposide.
Per Lindnér, D D Heath, D R Shalinsky, S B Howell, Peter Naredi, Lars-Olof Hafström
Surgical oncology - 1993 -
The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat
hepatoma.
Peter Naredi, Per Lindnér, Stig B Holmberg, U Stenram, A Peterson, Lars-Olof Hafström
International journal of cancer. Journal international du cancer - 1993 -
The influence of hepatic artery ligation and of vasopressin on liver tumour blood flow in
rats.
Peter Naredi, Per Lindnér, Stig B Holmberg, Rigmor Söderberg, Göran Carlsson, Bengt Gustavsson, Lars Jacobsson, Lars-Olof Hafström
Journal of surgical oncology - 1992 -
The influence of tumour type and of sphere size on microsphere nonentrapment-A study in the
rat.
Peter Naredi, Lars-Olof Hafström
Regional cancer treatment - 1992 -
Pharmacokinetics of cisplatin in an isolated liver perfusion system in
humans.
Peter Naredi, Stig B Holmberg, Lars-Olof Hafström, DD Heath, DR Shalinsky, SB Howell
Regional cancer treatment - 1992 -
Isolated hyperthermic liver perfusion with cytostatic-containing perfusate activates the complement
cascade.
J P Arnestad, Anders Bengtsson, Jan Peter Bengtson, Bengt-Åke Henriksson, Ola Stenqvist, Peter Naredi, Lars-Olof Hafström
The British journal of surgery - 1992 -
Influence of vasoactive drugs on microsphere nonentrapment in experimental rat
tumours.
Peter Naredi, J Matsson, Lars-Olof Hafström, L Jacobsson
Regional cancer treatment - 1991 -
Formation of anaphylatoxins and terminal complement complexes by perfusion of limbs with malignant
melanoma.
Anders Bengtsson, J P Arnestad, Jan Peter Bengtson, Bengt-Åke Henriksson, Ola Stenqvist, Peter Naredi, Lars-Olof Hafström
Regional cancer treatment - 1991 -
Aggregation of microspheres in blood flow
measurements.
Peter Naredi, Johan Mattsson, Lars-Olof Hafström
International journal of microcirculation, clinical and experimental / sponsored by the European Society for Microcirculation - 1991 -
Cytotoxicity of liver macrophages against liver tumours. Influence of betamethasone, indomethacin and
allopurinol.
Stig B Holmberg, Per Lindnér, Peter Naredi, Lars-Olof Hafström
Anticancer research - 1991 -
Evaluation of blood flow measurements with microspheres and rubidium--an experimental study in
rats.
Peter Naredi, J Mattson, Lars-Olof Hafström, Lars Jacobsson
International journal of microcirculation, clinical and experimental / sponsored by the European Society for Microcirculation - 1990 -
Liver parenchyma and liver tumour blood flow in normal and macrophage activated
rats.
Stig B Holmberg, Lars-Olof Hafström, Peter Naredi, L Jacobsson
Cells of the hepatic sinusoid. eds: Kirn A, Knook DL, Wisse E, vol2 - 1989 -
Techniques for measuring regional blood
flow.
J Mattsson, Lars-Olof Hafström, Peter Naredi, Hans-Inge Peterson
International journal of radiation oncology, biology, physics - 1987 -
Intratumoral distribution of
microspheres.
J Mattsson, Peter Naredi, Lars-Olof Hafström, H I Peterson
Anticancer research - 1986